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THE CARCINOGENIC effect of high doses
of oa benzene hexachloride (BHC) an
organochloride insecticide, has been re-
ported in the liver of rats treated with
this substance (Ito et al., 1975). BHC is
also known to inhibit the development
of hepatoma induced by 3'-methyl-4-
dimethyl-aminoazobenzene (3'-Me-DAB)
and DL-ethionine (Thamavit et al., 1974).
A preliminary study on the inhibitory
effects of BHC on aflatoxin B1 (AFB)
hepatocarcinogenesis in Fisher rats has
been previously reported from our labora-
tory (Angsubhakorn et al., 1978). This
paper describes morphological findings
after single and combined feedings of
BHC and AFB in male inbred Buffalo-
strain rats.
One hundred and ten male inbred
Buffalo rats, weighing 40-50 g, were used.
The basal diet has been previously
reported (Angsubhakorn et al., 1978).
The animals were divided into 4 groups
receiving the basal diet or basal diet
containing, (a) 500 pt/106 BHC (Tokyo
KaseiKoayaLtd,Japan), (b) 1 pt/106AFB
(Markor Chemicals Ltd, Jerusalem, Israel),
(c) 500 pt/106 BHC plus 1 pt/106 AFB.
All special diets and water given ad
libitum continuously for 35 weeks and
then replaced with Chow pellets (Gold
Coin Mill. PTE Ltd, Singapore) for 30
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weeks. Groups of animals were killed
after 18h starvation, at intervals of 5,
10, 15, 35 and 65 weeks (Table). The
relative liver weight as percentage of the
body weight in rats receiving BHC was
higher (i.e. 5*31% in BHC at week 10)
than that of the corresponding groups
without BHC.
Markedly enlarged livers, with smooth
surfaces, were found after 10 weeks
in the animals receiving BHC. The
livers in the animals receiving BHC +
AFB were slightly enlarged, with smooth
surfaces. Only a small white patch
was seen on the surface of the left
lateral lobe of the liver in one animal
of this group, at the end of 65 weeks.
The 6 animals which survived for 65
weeks in the AFB group all developed
liver tumours, and one showed multiple
metastatic foci scattered throughout all
lobes ofthe lung. There was no remarkable
change in the liver of rat fed either
BHC alone or the basal diet at Week 65.
Histological findings are summarized
in the Table. From 5-35 weeks, there was
centrilobular hypertrophy of heptocytes
due to both nuclear and cytoplasmic
enlargement, in the BHC and BHC+AFB
animals. These hypertrophic hepatocytes
also showedcytoplasmicinclusionsatWeek
35. These changes were reversible by
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TABLE.-Effects of BHC( and AFB, singly and jointly, on Buffalo rat liver for different
periods
No. of irats with
Centrolobular Foci of
No. of rats hypertrophic cellular
killed* lhepatocytes alterations
Week Week WAeek
Experimental ) A
groups 5 10 15 35 65 5 10 15 35 65 5 10 15 35 65
BHC 4 4 3 5 7 4 4 3 5 0 0 0 0 1
AFB 3 4 4 4 6 0 0 0 0 0 () 1 1 4 6
BHC +AFB 3 4 4 4 10 3 4 4 4 0 0 0 0 0 2
Basal diet 3 4 4 6 8 0 0 0 0 0 0 0 0 0 0
* A total of 16 rats that (lied (Iltring the experimenit have been exc(ludedl.
Week 65. Areas of acidophilic cell foci
were the predominant lesions in animals
killed at 35 weeks in the AFB group,
whereas only one acidophilic focus was
found in 1 out of the 5 rats receiving
BHC alone, and no similar foci were seen
in the BHC +AFB group at this time.
It was found that the addition of BHC
to the diet prevented the induction of
liver tumours by AFB after 65 weeks,
except for a single neoplastic nodule in
the liver of 1 out of 10 rats. The pre-
dominant type of liver tumour in the
AFB group was a pure well-differentiated
liver-cell carcinoma composed of either
uniform or mixed trabecullar and adeno-
carcinoma patterns. Furthermore, at Week
65, the number and size of the acidophilic
cell foci induced in group receiving
BHC +AFB were less than in rats re-
ceiving AFB. Only I out of 7 rats in the
BHC group developed an acidophilic
cell focus at Week 65.
The results of the present investigation,
as well as our preliminary study (Angsu-
bhakorn et al., 1978) demonstrate that
the additional dietary administration of
BHC for either 20 or 35 weeks was able
to inhibit the induction of liver tumours
by AFB in adult male Fisher and weanling
male Buffalo strain rats which survived
for 65 weeks.
BHC was found to induce hypertrophy
of the liver parenchymal cells of the
centrolobular areas. This finding con-
firmed the results of previous experiments
in rat (Ito et at., 1975; Angsubhakorn
et al., 1978) and mice (Ito et al., 1976).
In addition, we found large cytoplasmic
inclusions in the hypertrophic hepatic
cells of rats fed BHC. This was similar
to the effect of dichlorodiphenyl trichloro-
ethane (DDT) on rat liver (Ortega, 1966).
Previous reports on both light and
electron microscopy indicate that the
effect of phenobarbitone on rat liver
closely resembles that of DDT (Hart &
Fouts, 1 963; Herdson et al., 1964; Remmer
& Merker, 1965; Ortega, 1966). Pheno-
barbitone is known to reduce the carcino-
genic effect of aflatoxins (McLean &
Marshall, 1971; Swenson et al., 1.971).
We may, therefore, postulate that in the
AFB treated rats the tumour inhibitory
effects of BHC may be similar to those
ofphenobarbitone. Both BHC and pheno-
barbitone have been found to induce
hypertrophyandhyperplasiaofthehepato-
cytes, BHC being the more potent
(Schulte-Hermann et al., 1968). BHC and
phenobarbitone have also been found to
induce smooth endoplasmic reticulum
(SER) proliferation and microsomal
drug metabolizing enzymes of the liver
(Koransky et al., 1-964; Remmer & Merker,
1965; Thamavit et al., 1974). This evidence
suggests that BHC may increase the
hepatic detoxification of AFB and/or
stimulate the conversion of AFB to
non-carcinogenic metabolites.Another pos-
sible explanation for the inhibitory effect
of BHC on AFB carcinogenesis is that
BHC may decrease the binding of AFB
to nucleic acids, as occurs in pheno-
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barbitone-treated rats (Swenson et al.,
1971; Garner, 1975; Moule et al., 1975).
Thus, the increase in the rate of AFB
detoxification and the reduction in nucleic-
acid binding (probably due to competitive
inhibition) may account for the protective
effects ofBHC on aflatoxin carcinogenesis.
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